Abstract
Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication (P2.10-001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have